Pyrinide 250 Tablet contains Pyrazinamide 250mg, an antitubercular agent indicated for the treatment of active tuberculosis. It is typically used as part of combination therapy to ensure effective bacterial eradication and prevent the development of drug resistance.
Pyrazinamide works by targeting Mycobacterium tuberculosis in acidic environments, killing dormant bacteria within lesions and aiding in the sterilization of infected tissues. Its inclusion in combination regimens accelerates therapy and improves treatment outcomes.
For distributors and healthcare suppliers, Pyrinide 250 Tablet is a high-demand antitubercular therapy product, commonly used in hospitals, TB clinics, government health initiatives, and community healthcare programs. The ongoing prevalence of tuberculosis guarantees steady demand throughout the year.
Adding Pyrinide 250 Tablet to your antitubercular therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its proven clinical efficacy, prescriber confidence, and essential role in TB treatment make it a valuable addition to pharmaceutical distribution portfolios.